hVIVO plc (LON:HVO – Get Free Report) shares crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 24.90 ($0.31) and traded as low as GBX 19 ($0.24). hVIVO shares last traded at GBX 19.50 ($0.24), with a volume of 606,288 shares.
hVIVO Price Performance
The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61. The firm has a market capitalization of £133.05 million, a P/E ratio of 651.83 and a beta of 0.97. The stock has a 50 day moving average of GBX 24.60 and a two-hundred day moving average of GBX 27.08.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
See Also
- Five stocks we like better than hVIVO
- Are Penny Stocks a Good Fit for Your Portfolio?
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- Why Are Stock Sectors Important to Successful Investing?
- 2 Drone Stocks Surging from Increased Media Attention
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
